Using a peptide with an amino-terminal palmitoyl-lysine adduct for cell permeation, Egwuagu and colleagues also showed that topical application of SOCS1-KIR could prevent pathology in rodent models of autoimmune uveitis, if delivered from the time of immunization (94, 95). Here, SOCS1 is linked to autoimmune uveitis.